Literature DB >> 35717504

Designed Ankyrin Repeat Proteins as a tool box for analyzing p63.

Alexander Strubel1, Philipp Münick1, Apirat Chaikuad2,3, Birgit Dreier4, Jonas Schaefer4, Jakob Gebel1, Christian Osterburg1, Marcel Tuppi1, Birgit Schäfer1, Stefan Knapp2,3, Andreas Plückthun4, Volker Dötsch5.   

Abstract

The function of the p53 transcription factor family is dependent on several folded domains. In addition to a DNA-binding domain, members of this family contain an oligomerization domain. p63 and p73 also contain a C-terminal Sterile α-motif domain. Inhibition of most transcription factors is difficult as most of them lack deep pockets that can be targeted by small organic molecules. Genetic knock-out procedures are powerful in identifying the overall function of a protein, but they do not easily allow one to investigate roles of individual domains. Here we describe the characterization of Designed Ankyrin Repeat Proteins (DARPins) that were selected as tight binders against all folded domains of p63. We determine binding affinities as well as specificities within the p53 protein family and show that DARPins can be used as intracellular inhibitors for the modulation of transcriptional activity. By selectively inhibiting DNA binding of the ΔNp63α isoform that competes with p53 for the same promoter sites, we show that p53 can be reactivated. We further show that inhibiting the DNA binding activity stabilizes p63, thus providing evidence for a transcriptionally regulated negative feedback loop. Furthermore, the ability of DARPins to bind to the DNA-binding domain and the Sterile α-motif domain within the dimeric-only and DNA-binding incompetent conformation of TAp63α suggests a high structural plasticity within this special conformation. In addition, the developed DARPins can also be used to specifically detect p63 in cell culture and in primary tissue and thus constitute a very versatile research tool for studying the function of p63.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35717504     DOI: 10.1038/s41418-022-01030-y

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  55 in total

Review 1.  Stability engineering of antibody single-chain Fv fragments.

Authors:  A Wörn; A Plückthun
Journal:  J Mol Biol       Date:  2001-02-02       Impact factor: 5.469

Review 2.  DARPins and other repeat protein scaffolds: advances in engineering and applications.

Authors:  Ykelien L Boersma; Andreas Plückthun
Journal:  Curr Opin Biotechnol       Date:  2011-06-27       Impact factor: 9.740

Review 3.  Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy.

Authors:  Andreas Plückthun
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015       Impact factor: 13.820

Review 4.  Chemoproteomics and Chemical Probes for Target Discovery.

Authors:  Gerard Drewes; Stefan Knapp
Journal:  Trends Biotechnol       Date:  2018-07-13       Impact factor: 19.536

5.  High-affinity binders selected from designed ankyrin repeat protein libraries.

Authors:  H Kaspar Binz; Patrick Amstutz; Andreas Kohl; Michael T Stumpp; Christophe Briand; Patrik Forrer; Markus G Grütter; Andreas Plückthun
Journal:  Nat Biotechnol       Date:  2004-04-18       Impact factor: 54.908

6.  Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases.

Authors:  Petra Parizek; Lutz Kummer; Peter Rube; Anke Prinz; Friedrich W Herberg; Andreas Plückthun
Journal:  ACS Chem Biol       Date:  2012-05-25       Impact factor: 5.100

7.  A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm.

Authors:  Pascal Philibert; Audrey Stoessel; Wei Wang; Annie-Paule Sibler; Nicole Bec; Christian Larroque; Jeffery G Saven; Jérôme Courtête; Etienne Weiss; Pierre Martineau
Journal:  BMC Biotechnol       Date:  2007-11-22       Impact factor: 2.563

8.  A chemical toolbox for the study of bromodomains and epigenetic signaling.

Authors:  Qin Wu; David Heidenreich; Stanley Zhou; Suzanne Ackloo; Andreas Krämer; Kiran Nakka; Evelyne Lima-Fernandes; Genevieve Deblois; Shili Duan; Ravi N Vellanki; Fengling Li; Masoud Vedadi; Jeffrey Dilworth; Mathieu Lupien; Paul E Brennan; Cheryl H Arrowsmith; Susanne Müller; Oleg Fedorov; Panagis Filippakopoulos; Stefan Knapp
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

9.  Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization.

Authors:  Nikolas Friedrich; Emanuel Stiegeler; Matthias Glögl; Thomas Lemmin; Simon Hansen; Claus Kadelka; Yufan Wu; Patrick Ernst; Liridona Maliqi; Caio Foulkes; Mylène Morin; Mustafa Eroglu; Thomas Liechti; Branislav Ivan; Thomas Reinberg; Jonas V Schaefer; Umut Karakus; Stephan Ursprung; Axel Mann; Peter Rusert; Roger D Kouyos; John A Robinson; Huldrych F Günthard; Andreas Plückthun; Alexandra Trkola
Journal:  Nat Commun       Date:  2021-11-18       Impact factor: 14.919

Review 10.  Trends in kinase drug discovery: targets, indications and inhibitor design.

Authors:  Misty M Attwood; Doriano Fabbro; Aleksandr V Sokolov; Stefan Knapp; Helgi B Schiöth
Journal:  Nat Rev Drug Discov       Date:  2021-08-05       Impact factor: 84.694

View more
  1 in total

Review 1.  p73 isoforms meet evolution of metastasis.

Authors:  Stella Logotheti; Athanasia Pavlopoulou; Stephan Marquardt; Işıl Takan; Alexandros G Georgakilas; Thorsten Stiewe
Journal:  Cancer Metastasis Rev       Date:  2022-08-11       Impact factor: 9.237

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.